Center for Global Health R&D Policy Assessment

Follow us on:

Global Health Accelerator

The Global Health Accelerator, a proposed mechanism to capitalize on the growing pool of innovation and local expertise in developing countries, would provide a suite of support services to biotechnology firms in emerging markets. In particular, the Accelerator would target firms undertaking research and product development for neglected disease technologies. The services would include business support services, partnering opportunities with Product Development Partnerships and Northern researchers and other forms of capacity building assistance.

Implementation status: 
No
Champion: 

McLaughlin-Rotman Centre for Global Health (Peter Singer and colleagues)

Sources: 

Frew, Sarah E., Victor Y. Liu and Peter A. Singer. “A Business Plan To Help The ‘Global South’ In Its Fight Against Neglected Diseases.” Health Affairs Vol. 28, No. 6 (November 2009): 1760 – 1773. Available here.